Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Next Generation Internet ETF (ARKW) vs Medpace Holdings Inc (MEDP) Price & Performance

ARK Next Generation Internet ETFTrade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

ARK Next Generation Internet ETF vs Medpace Holdings Inc — how do they compare? ARK Next Generation Internet ETF trades at $150.74, while Medpace Holdings Inc trades at $597.39 (market cap $16.90B). The key difference: Medpace Holdings Inc is trading nearer its 52-week high, ARK Next Generation Internet ETF nearer its low. Which is the better fit depends on your goals.

ARKWMEDP
Sector
Sector/ThematicTechnology
52-Week High
$182.20$620.59
52-Week Low
$114.45$393.42
Market Cap
$16.90B
Enterprise Value
$16.52B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ARK Next Generation Internet ETF

ARKW trades at $151.13, up 1.04% with strong technical momentum as moving averages signal bullish alignment. The ETF faces near-term headwinds from elevated AI infrastructure spending but maintains long-term growth positioning in next-generation internet technologies. Technical indicators show mixed signals with RSI suggesting potential overbought conditions while ADX confirms strong trend strength.

The ETF's outlook balances near-term capital expenditure pressures against long-term AI and technology exposure. Key risks include market skepticism toward growth stocks and concentration in volatile tech holdings. Analyst sentiment remains cautious with a Hold rating due to current market conditions despite the fund's innovative portfolio positioning.

Medpace Holdings Inc

MEDP trades at $596.98, down 0.9% on the day but near its 52-week highs. The stock shows strong technical momentum with bullish moving averages and recent golden cross formation. Fundamentally, the company delivered three consecutive quarterly earnings beats with Q2 2026 EPS of $4.25 beating expectations of $3.98. Revenue growth remains robust at 17.2% year-over-year in Q2 2026, supported by record net bookings and a $3.0 billion backlog.

MEDP presents a growth story with strong fundamentals but trades at premium valuations (P/E 35.58, P/S 6.27). The primary investment opportunity lies in continued execution on record bookings and backlog conversion. Key risks include the ongoing shareholder litigation investigation and potential valuation compression if growth moderates. Analyst consensus targets $599.57 with 21% buy ratings, suggesting limited near-term upside from current levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ARK Next Generation Internet ETF

ARKW is an actively managed ETF that invests in next-generation internet technologies. It focuses on cloud computing, AI, e-commerce, and blockchain innovation, with key holdings like Tesla, Advanced Micro Devices, and Roku.

Read more on ARKW

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP